About Galaxy Diagnostics
Galaxy Diagnostics is a private company based in Durham, North Carolina. It has reported $9,777,643 raised in five offerings on Form D since May 2009. Its chief executive is Nicole Bell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 1, 2026 | Jun 3, 2026 | $3,019,645of $5.6M target | 45 | $67,103 | EquityRule 506(b) | Form D ↗ |
| Apr 9, 2025 | Apr 22, 2025 | $4,141,184of $11.1M target | 55 | $75,294 | EquityRule 506(b) | Form D ↗ |
| Aug 11, 2023 | Jul 10, 2024amended Jul 31, 2024 | $2,026,000of $3.0M target | 27 | $75,037 | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 29, 2014 | Aug 15, 2014 | $550,814of $1.0M target | 7 | $78,688 | EquityRule 506(b) | Form D ↗ |
| Apr 22, 2009 | May 12, 2009 | $40,000of $100K target | 3 | $13,333 | Debt06 | Form D ↗ |
| Total, five offerings | $9,777,643 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Galaxy Diagnostics's Form D filed Jun 3, 2026.
AE
JK
Joel Kimbrough
Director
NB
EB
Edward Breitschwerdt
Director
BC
B. Clark
Executive officer and director
RW
Richard West
Director
Earlier filings also listed Ricardo Maggi (director, last listed Aug 2014) and Christopher Kelly (executive officer and director, last listed May 2009).